NCT03243903View on ClinicalTrials.gov

Comparison of Safety and Efficacy of QS-M Needle- Free Injector and Insulin Pen in Controlling T2DM Patient's Glucose

NACompletedINTERVENTIONAL
Enrollment

427

Participants

Timeline

Start Date

August 18, 2017

Primary Completion Date

November 8, 2018

Study Completion Date

November 8, 2018

Conditions
Diabetes
Interventions
DEVICE

QS-M insulin-free injector

Using QS-M insulin-free injector as insulin carrier to control blood glucose of T2DM and insulin dose is prescribed.

DEVICE

conventional insulin pen

Using conventional insulin pen as insulin carrier to control blood glucose of T2DM and insulin dose is prescribed.

Trial Locations (1)

10000

Peking University People 's Hospital, Beijing

All Listed Sponsors
lead

Beijing QS Medical Technology Co., Ltd.

INDUSTRY

NCT03243903 - Comparison of Safety and Efficacy of QS-M Needle- Free Injector and Insulin Pen in Controlling T2DM Patient's Glucose | Biotech Hunter | Biotech Hunter